Vivaldi Coelho Rogerio sold CRNX
March 12, 2026 · Form 4 insider transaction
Vivaldi Coelho Rogerio sold 523 shares of Crinetics Pharmaceuticals Inc at $36.77 per share, a transaction worth $19.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.; The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $36.77 per share. The range of sales prices on the transaction date was $36.69 to $36.89 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request.